We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Predictors Evaluated for Microalbuminuria in Type 2 Diabetes

By LabMedica International staff writers
Posted on 12 Mar 2020
Chronic inflammation has an important role in the development and progression of type 2 diabetes through immunologic inflammatory mechanisms. More...
The neutrophil‐to‐lymphocyte ratio (NLR) is a new, simple, and inexpensive marker of subclinical inflammation and has been used as a systemic inflammatory marker in chronic diseases.

A symptom of nephropathy is albuminuria usually initiating with microalbuminuria, which was found to be a marker of vascular endothelial damage. Albuminuria is a well‐known predictor of poor renal outcomes in patients with type 2 diabetes and in essential hypertension and as such, it is important to monitor and diagnose in order to treat early.

A team of medical scientists working with the Ziv Medical Center (Safed, Israel) included in their study the data from 168 patients with type 2 diabetes mellitus (DM), which included patients aged ≥40 years old who had type 2 DM for at least four years. Patients were classified into three groups according to glycated hemoglobin (HbA1c) and microalbuminuria: Group A were patients with controlled diabetes; Group B were patients with uncontrolled diabetes (both groups without microalbuminuria); and Group C, were patients with uncontrolled diabetes with microalbuminuria.

The team examined the patients records regarding plasma glucose, HbA1c, creatinine, albumin, total cholesterol, triglycerides (TG), high‐density lipoprotein (HDL), and low‐density lipoprotein (LDL) levels in the venous blood samples obtained in the morning after 8‐hours fasting. Complete blood counts were analyzed in the hematology unit with a Beckman‐Coulter Gen‐S hematology analyzer (Beckman Coulter Inc., Brea, CA, USA). Mean platelet volume (MPV) and red blood cell distribution width (RDW) levels were gathered from patients' complete blood count, and NLR was calculated as the ratio of absolute number of neutrophil and lymphocyte counts.

The scientists reported that a significant difference in NLR was found between Group C and groups A and B. A statistically significant difference in RDW was found between groups B and C. Receiver operating characteristic curve analysis of inflammatory markers and microalbuminuria prediction showed an area under curve (AUC) of 0.675 for NLR and 0.614 for RDW. NLR value of 2.54 has 39.7% sensitivity, 78.8% specificity, and 45% positive predictive value (PPV). RDW value of 14.44% has 37.9% sensitivity, 76% specificity, and 41.5% PPV. TG/HDL ratio was lower in patients with controlled diabetes (group A) compared to the other two groups. Serum creatinine was higher as was the ratio to microalbumin in group C compared to the other two study groups.

The authors concluded that high levels of NLR were found in diabetic patients with microalbuminuria compared to controlled and uncontrolled patients without microalbuminuria. At the same time, they found high RDW values in patients with diabetes with microalbuminuria compared to diabetic patients without microalbuminuria. The study was published on February 25, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Ziv Medical Center
Beckman Coulter Inc



New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Spatial profiling of muscle-invasive bladder cancer reveals how distinct tumor cell states are organized within individual tumors (Image Credit: Shutterstock)

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer is clinically heterogeneous, with patients often responding very differently to therapy. Existing biomarkers do not fully explain these disparities, limiting precision treatment... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.